Stock Screener App

Frei -

Installieren

23.61

7.03% 1.55

after-market

Handel nachbörslich: 23.61

Celldex Therapeutics Inc (CLDX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Celldex Therapeutics Inc-Aktie (CLDX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	5.04% 0.73	0.695	1.175	3.191	2.498
Operating Expenses	1.82% 64.59	63.43	57.00	55.32	48.81
Benefits Costs and Expenses	1.82% 64.59	63.43	19.99	55.32	48.81
Costs And Expenses	1.82% 64.59	63.43	57.20	55.32	48.81
Operating Income/Loss	1.78% -63.86	-62.74	-56.03	-52.13	-46.32
Income/Loss From Continuing Operations Before Tax	18.70% -63.86	-53.80	-18.81	-52.13	-35.84
Income/Loss From Continuing Operations After Tax	5.21% -56.60	-53.80	-7.271	-42.12	-35.84
Net Income/Loss	5.21% -56.60	-53.80	-47.09	-42.12	-35.84
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.01% 0.0664	0.0664	0.000658	0.0663	0.066
Diluted Average Shares	0.01% 0.0664	0.0664	0.000658	0.0663	0.066
Basic Earnings Per Share	4.94% -0.85	-0.81	-0.71	-0.64	-0.54
Diluted Earnings Per Share	4.94% -0.85	-0.81	-0.71	-0.64	-0.54
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$86.96

1.14%

GMAB

$27.08

4.60%

SMMT

$23.52

1.34%

BNTX

$100.42

0.20%

INSM

$143.50

1.24%

ONC

$336.26

1.27%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters